These Analysts Revise Their Forecasts On Braze Following Q2 Results

Braze Inc. (BRZE) reported stronger-than-expected fiscal second-quarter 2026 results, with revenue of $180.1 million (up 23.8% YoY) and non-GAAP EPS of $0.15, both significantly beating analyst estimates. The company also substantially raised its full-year FY2026 revenue and non-GAAP EPS outlook to $717.0-$720.0 million and $0.41-$0.42, respectively, well above prior guidance and consensus. This robust performance, attributed partly to a focus on AI solutions for customer engagement, led to a 10.5% surge in BRZE shares and prompted multiple analysts to raise their price targets while reiterating positive ratings.

Analysis

Braze Inc. delivered a robust fiscal second-quarter 2026 performance, significantly exceeding expectations and signaling a material acceleration in profitability. The company reported a 23.8% year-over-year revenue increase to $180.1 million, comfortably beating the $170.1 million consensus estimate. More impressively, non-GAAP EPS came in at $0.15, quintupling the 3-cent analyst estimate and demonstrating strong operating leverage as net income nearly doubled from the prior year. The forward-looking guidance reinforces this positive trajectory; for the full fiscal year 2026, Braze elevated its revenue forecast to a range of $717.0-$720.0 million, but the most significant revision was to its non-GAAP EPS outlook, which was more than doubled to $0.41-$0.42 from a prior range of $0.15-$0.18. This substantial upward revision, which the CEO links to the firm's focus on high-ROI AI solutions, triggered a 10.5% rally in the stock and a wave of positive analyst revisions. Multiple firms, including Piper Sandler and Citigroup, reiterated Buy-equivalent ratings and raised price targets, with new targets ranging from $38 to $52, reflecting strong institutional conviction.

Key Decisions for Investors

• Investors should recognize the significant inflection in profitability, evidenced by the more than doubling of the full-year EPS forecast, which strengthens the bull thesis and suggests strong operating leverage is taking hold.
• Despite the 10.5% share price increase, the stock at $30.67 remains well below the newly raised analyst price targets, which now largely fall in the $38 to $52 range, indicating potential for further appreciation if momentum continues.
• It is critical to monitor the company's ability to execute against its substantially raised guidance in subsequent quarters, as sustained performance will be necessary to justify the market's heightened expectations and validate the AI-driven growth narrative.